Macquarie Group LTD Durect Corp Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.9 - $1.31 $3,403 - $4,954	-3,782 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$1.86 - $2.87 $3,334 - $5,145	-1,793 Reduced 32.16%	3,782 $7,000
Q2 2020 Aug 11, 2020	SELL	$1.33 - $2.76 $33,236 - $68,972	-24,990 Reduced 81.76%	5,575 $13,000
Q1 2020 May 15, 2020	BUY	$0.97 - $2.85 $29,648 - $87,110	30,565 New	30,565 $47,000
Q4 2017 Feb 15, 2018	SELL	$0.78 - $2.1 $36,991 - $99,592	-47,425 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$1.55 - $1.82 $73,508 - $86,313	47,425	47,425 $84,000

591K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $298M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.